Effect of calcium supplementation on bone resorption in pregnancy and the early postpartum: a randomized controlled trial in Mexican women

Adrienne S Ettinger, Héctor Lamadrid-Figueroa, Adriana Mercado-García, Katarzyna Kordas, Richard J Wood, Karen E Peterson, Howard Hu, Mauricio Hernández-Avila, Martha M Téllez-Rojo, Adrienne S Ettinger, Héctor Lamadrid-Figueroa, Adriana Mercado-García, Katarzyna Kordas, Richard J Wood, Karen E Peterson, Howard Hu, Mauricio Hernández-Avila, Martha M Téllez-Rojo

Abstract

Background: Calcium needs are physiologically upregulated during pregnancy and lactation to meet demands of the developing fetus and breastfeeding infant. Maternal calcium homeostasis is maintained by hormonal adaptive mechanisms, thus, the role of dietary calcium supplementation in altering maternal responses to fetal-infant demand for calcium is thought to be limited. However, increased calcium absorption is directly related to maternal calcium intake and dietary supplementation has been suggested to prevent transient bone loss associated with childbearing.

Methods: In a double-blind, randomized placebo-controlled trial, we randomly assigned 670 women in their first trimester of pregnancy to 1,200 mg/day calcium (N = 334) or placebo (N = 336). Subjects were followed through 1-month postpartum and the effect on urinary cross-linked N-telopeptides (NTx) of type I collagen, a specific marker of bone resorption, was evaluated using an intent-to-treat analysis. Women with a baseline and at least one follow-up measurement (N = 563; 84%) were included. Subsequent analyses were conducted stratifying subjects by compliance assessed using pill counts. In random subsets of participants, bone-specific alkaline phosphatase (BAP) (N = 100) and quantitative ultrasound (QUS) (N = 290) were also measured.

Results: Calcium was associated with an overall reduction of 15.8% in urinary NTx relative to placebo (p < 0.001). Among those who consumed ≥50%, ≥67%, and ≥75% of pills, respectively, the effect was associated with 17.3%, 21.3%, and 22.1% reductions in bone resorption (all p < 0.001). There was no significant effect of calcium on bone formation measured by BAP. However, by 1-month postpartum, those in the calcium group had significantly lower NTx/BAP ratios than those in the placebo group (p = 0.04) indicating a net reduction in bone loss in the supplement group by the end of follow-up. Among subjects who consumed ≥50% and ≥75% of pills, respectively, calcium was also associated with an increase of 26.3 m/s (p = 0.03) and 59.0 m/s (p = 0.009) in radial SOS relative to placebo by 1-month postpartum.

Conclusions: Calcium administered during pregnancy and the early postpartum period, to women with intakes around adequacy, was associated with reduced bone resorption and, thus, may constitute a practical intervention to prevent transient skeletal loss associated with childbearing.

Trial registration: ClinicalTrials.gov Identifier NCT00558623.

Figures

Figure 1
Figure 1
Study sample profile.
Figure 2
Figure 2
Effect of calcium supplementation on urinary N-telopeptides of type I collagen [NTx] (nM BCE/mM creatinine) at each trimester during pregnancy and at 1-month postpartum (Intent-to-Treat Analysis, N = 563); adjusting for baseline variables: NTx, age, primigravidity, dietary calcium and daily energy intake.

References

    1. Prentice A. Calcium in pregnancy and lactation. Annu Rev Nutr. 2000;20:249–272. doi: 10.1146/annurev.nutr.20.1.249.
    1. Hacker AN, Fung EB, King JC. Role of calcium during pregnancy: maternal and fetal needs. Nutr Rev. 2012;70:397–409. doi: 10.1111/j.1753-4887.2012.00491.x.
    1. Kovacs CS. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab. 2001;86:2344–2348.
    1. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev. 1997;18:832–872.
    1. Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NE. Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr. 1995;61:514–523.
    1. Ritchie LD, Fung EB, Halloran BP, Turnlund JR, Van Loan MD, Cann CE, King JC. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr. 1998;67:693–701.
    1. Sowers M, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, Randolph JF, Hollis B. Changes in bone density with lactation. JAMA. 1993;269:3130–3135. doi: 10.1001/jama.1993.03500240074029.
    1. Sowers MF, Scholl T, Harris L, Jannausch M. Bone loss in adolescent and adult pregnant women. Obstet Gynecol. 2000;96:189–193. doi: 10.1016/S0029-7844(00)00903-0.
    1. Kalkwarf HJ, Specker BL. Bone mineral changes during pregnancy and lactation. Endocrine. 2002;17:49–53. doi: 10.1385/ENDO:17:1:49.
    1. Purdie DW, Aaron JE, Selby PL. Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol. 1988;95:849–854. doi: 10.1111/j.1471-0528.1988.tb06568.x.
    1. Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res. 2000;15:129–137. doi: 10.1359/jbmr.2000.15.1.129.
    1. Yamaga A, Taga M, Minaguchi H. Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium. Endocr J. 1997;44:733–738. doi: 10.1507/endocrj.44.733.
    1. Pagani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest. 2005;28(10 Suppl):8–13.
    1. Hellmeyer L, Ziller V, Anderer G, Ossendorf A, Schmidt S, Hadji P. Biochemical markers of bone turnover during pregnancy: a longitudinal study. Exp Clin Endocrinol Diabetes. 2006;114:506–510. doi: 10.1055/s-2006-951627.
    1. Holroyd C, Harvey N, Dennison E, Cooper C. Epigenetic influences in the developmental origins of osteoporosis. Osteoporos Int. 2012;23:401–410. doi: 10.1007/s00198-011-1671-5.
    1. Zhu K, Whitehouse AJ, Hart P, Kusel M, Mountain J, Lye S, Pennell C, Walsh JP. Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study. J Bone Miner Res. 2014;29:1088–1095. doi: 10.1002/jbmr.2138.
    1. Lawlor DA, Wills AK, Fraser A, Sayers A, Fraser WD, Tobias JH. Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study. Lancet. 2013;381:2176–2183. doi: 10.1016/S0140-6736(12)62203-X.
    1. Institute of Medicine . Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: National Academies Press; 2011.
    1. Avendaño-Badillo D, Hernández-Avila M, Hernández-Cadena L, Rueda-Hernández G, Solano-González M, Ibarra LG, Hu H, Téllez-Rojo MM. High dietary calcium intake decreases bone mobilization during pregnancy in humans. Salud Publica Mex. 2009;51(Suppl 1):S100–S107.
    1. Zeni SN, Ortela Soler CR, Lazzari A, López L, Suarez M, Di Gregorio S, Somoza JI, de Portela ML. Interrelationship between bone turnover markers and dietary calcium intake in pregnant women: a longitudinal study. Bone. 2003;33:606–613. doi: 10.1016/S8756-3282(03)00203-5.
    1. Weisman SM, Matkovic V. Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture risk. Clin Ther. 2005;27:299–308. doi: 10.1016/j.dinthera.2005.03.003.
    1. Olausson H, Goldberg GR, Laskey MA, Schoenmakers I, Jarjou LM, Prentice A. Calcium economy in human pregnancy and lactation. Nutr Res Rev. 2012;25:40–67. doi: 10.1017/S0954422411000187.
    1. Janakiraman V, Ettinger A, Mercado-Garcia A, Hu H, Hernandez-Avila M. Calcium supplements and bone resorption in pregnancy: a randomized crossover trial. Am J Prev Med. 2003;24:260–264. doi: 10.1016/S0749-3797(02)00641-4.
    1. Jarjou LM, Laskey MA, Sawo Y, Goldberg GR, Cole TJ, Prentice A. Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. Am J Clin Nutr. 2010;92:450–457. doi: 10.3945/ajcn.2010.29217.
    1. Liu Z, Qiu L, Chen YM, Su YX. Effect of milk and calcium supplementation on bone density and bone turnover in pregnant Chinese women: a randomized controlled trial. Arch Gynecol Obstet. 2011;283:205–211. doi: 10.1007/s00404-009-1345-0.
    1. U.S. Pharmacopeia . USP Dietary Supplements Compendium. Rockville MD: U.S. Pharmacopeia; 2012.
    1. Zhu YI, Haas JD. Response of serum transferrin receptor to iron supplementation in iron-depleted, nonanemic women. Am J Clin Nutr. 1998;67:271–275.
    1. Institute of Medicine . Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Washington DC: National Academy Press; 1997. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride.
    1. National Research Council . Subcommittee on the Tenth Edition of the RDAs. Food and Nutrition Board. Commission on Life Sciences. 10. Washington DC: National Academy Press; 1989. Recommended Dietary Allowances.
    1. Institute of Medicine . Subcommittee on Dietary Intake and Nutrient Supplements During Pregnancy. Committee on Nutritional Status During Pregnancy. Food and Nutrition Board. Washington DC: National Academy Press; 1990. Nutrition During Pregnancy: Part II: Nutrient Supplements.
    1. Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R. The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab. 1994;79:730–735.
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497. doi: 10.1056/NEJMra050100.
    1. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 1992;7:1251–1258. doi: 10.1002/jbmr.5650071119.
    1. Garnero P, Delmas P. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrin Metab. 1993;77:1046–1053.
    1. Van Straalen JP, Sanders E, Prummel MF, Sanders GT. Bone alkaline phosphatase as indicator of bone formation. Clin Chim Acta. 1991;201:27–33. doi: 10.1016/0009-8981(91)90021-4.
    1. National Institutes of Health . NIH Consensus Statement Online. 17. 2000. Osteoporosis prevention, diagnosis, and therapy; pp. 1–36.
    1. Della Martina M, Biasioli A, Vascotto L, Rinuncini D, Adorati Menegato A, Liva S, Londero AP, Driul L, Marchesoni D. Bone ultrasonometry measurements during pregnancy. Arch Gynecol Obstet. 2010;281:401–407. doi: 10.1007/s00404-009-1133-x.
    1. Hellmeyer L, Ossendorf A, Ziller V, Tekesin I, Schmidt S, Hadji P. Quantitative ultrasonometry of the phalanges during pregnancy: a longitudinal study. Climacteric. 2006;9:446–451. doi: 10.1080/13697130601006048.
    1. To WW, Wong MW, Leung TW. Relationship between bone mineral density changes in pregnancy and maternal and pregnancy characteristics: a longitudinal study. Acta Obstet Gynecol Scand. 2003;82:820–827. doi: 10.1034/j.1600-0412.2003.00227.x.
    1. Hernandez-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex. 1998;40:133–140. doi: 10.1590/S0036-36341998000200005.
    1. Rosen CJ, Chesnut CH, 3rd, Mallinak NJ. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endo Metabol. 1997;82:1904–1910.
    1. Jarjou LM, Sawo Y, Goldberg GR, Laskey MA, Cole TJ, Prentice A. Unexpected long-term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow-up study. Am J Clin Nutr. 2013;98:723–730. doi: 10.3945/ajcn.113.061630.
    1. Prins SH, Jørgensen HL, Jørgensen LV, Hassager C. The role of quantitative ultrasound in the assessment of bone: a review. Clin Physiol. 1998;18:3–17. doi: 10.1046/j.1365-2281.1998.00067.x.
    1. Knapp KM. Quantitative ultrasound and bone health. Salud Publica Mex. 2009;51(Suppl 1):S18–S24.
    1. Trimpou P, Bosaeus I, Bengtsson BA, Landin-Wilhelmsen K. High correlation between quantitative ultrasound and DXA during 7 years of follow-up. Eur J Radiol. 2010;73:360–364. doi: 10.1016/j.ejrad.2008.11.024.
    1. Bonjour JP, Chevalley T, Ferrari S, Rizzoli R. The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex. 2009;51(Suppl 1):S5–S17.
    1. Jones G. Early life nutrition and bone development in children. Nestle Nutr Workshop Ser Pediatr Program. 2011;68:227–233. doi: 10.1159/000325910.
    1. Cooper C, Harvey N, Cole Z, Hanson M, Dennison E. Developmental origins of osteoporosis: the role of maternal nutrition. Adv Exp Med Biol. 2009;646:31–39. doi: 10.1007/978-1-4020-9173-5_3.
    1. Johnson MA. High calcium intake blunts pregnancy-induced increases in maternal blood lead. Nutr Rev. 2001;59:152–156.
    1. Harvey NC, Holroyd C, Ntani G, Javaid K, Cooper P, Moon R, Cole Z, Tinati T, Godfrey K, Dennison E, Bishop NJ, Baird J, Cooper C. Vitamin D supplementation in pregnancy: a systematic review. Health Technol Assess. 2014;18:1–190. doi: 10.3310/hta18450.
    1. Diogenes ME, Bezerra FF, Rezende EP, Taveira MF, Pinhal I, Donangelo CM. Effect of calcium plus vitamin D supplementation during pregnancy in Brazilian adolescent mothers: a randomized, placebo-controlled trial. Am J Clin Nutr. 2013;98(1):82–91. doi: 10.3945/ajcn.112.056275.
    1. Thomas M, Weisman SM. Calcium supplementation during pregnancy and lactation: effects on the mother and the fetus. Am J Obstet Gynecol. 2006;194:937–945. doi: 10.1016/j.ajog.2005.05.032.
    1. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;6:CD001059.
    1. Imdad A, Jabeen A, Bhutta ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC Public Health. 2011;11(Suppl 3):S18. doi: 10.1186/1471-2458-11-S3-S18.
    1. Hofmeyr GJ, Belizán JM, von Dadelszen P, Calcium and Pre-eclampsia (CAP) Study Group Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary. Br J Obstet Gynaecol. 2014;121:951–957. doi: 10.1111/1471-0528.12613.
    1. Patrelli TS, Dall’asta A, Gizzo S, Pedrazzi G, Piantelli G, Jasonni VM, Modena AB. Calcium supplementation and prevention of preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med. 2012;25:2570–2574. doi: 10.3109/14767058.2012.715220.
    1. Ettinger AS, Lamadrid-Figueroa H, Téllez-Rojo MM, Mercado-García A, Peterson KE, Schwartz J, Hu H, Hernández-Avila M. Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environ Health Perspect. 2009;117:26–31. doi: 10.1289/ehp.11868.
    1. World Health Organization . Calcium Supplementation in Pregnant Women. Geneva: World Health Organization; 2013.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe